{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T14:50:38Z","timestamp":1762095038620,"version":"build-2065373602"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.bbrc.2023.04.114","type":"journal-article","created":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T10:50:58Z","timestamp":1683370258000},"page":"138-145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Structure-activity relationship of dihydropyridines for rhabdomyosarcoma"],"prefix":"10.1016","volume":"667","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7714-8706","authenticated-orcid":false,"given":"Shefali","family":"Chauhan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew D.","family":"Woods","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narendra","family":"Bharathy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolei","family":"Lian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cora A.","family":"Ricker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Mantz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William J.","family":"Zuercher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa H.","family":"Price","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Morton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Durrant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane Y.","family":"Corbel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srinath C.","family":"Sampath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srihari C.","family":"Sampath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Joslin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Keller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2023.04.114_bib1","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26645","article-title":"Histology, fusion status, and outcome in metastatic rhabdomyosarcoma: a report from the Children's Oncology Group","volume":"64","author":"Rudzinski","year":"2017","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.bbrc.2023.04.114_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-018-0051-2","article-title":"Rhabdomyosarcomas","volume":"5","author":"Skapek","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.bbrc.2023.04.114_bib3","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/pbc.20466","article-title":"Rhabdomyosarcomas utilize developmental, myogenic growth factors for disease advantage: a report from the Children's Oncology Group","volume":"46","author":"Blandford","year":"2006","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.bbrc.2023.04.114_bib4","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1101\/gad.238733.114","article-title":"Lineage of origin in rhabdomyosarcoma informs pharmacological response","volume":"28","author":"Abraham","year":"2014","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbrc.2023.04.114_bib5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ccr.2010.12.023","article-title":"Evidence for an unanticipated relationship between undifferentiated pleomorphic sarcoma and embryonal rhabdomyosarcoma","volume":"19","author":"Rubin","year":"2011","journal-title":"Cancer Cell"},{"year":"2021","series-title":"Functional States of the Ryanodine Receptor (RyR) and 3D Structure of the Triad Junction","author":"Wadsworth","key":"10.1016\/j.bbrc.2023.04.114_bib20"},{"key":"10.1016\/j.bbrc.2023.04.114_bib21","doi-asserted-by":"crossref","first-page":"12309","DOI":"10.1016\/S0021-9258(18)45353-7","article-title":"Identification and characterization of the dihydropyridine-binding subunit of the skeletal muscle dihydropyridine receptor","volume":"262","author":"Sharp","year":"1987","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2023.04.114_bib6","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1126\/science.2158672","article-title":"Primary structure of the gamma subunit of the DHP-sensitive calcium channel from skeletal muscle","volume":"248","author":"Jay","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2023.04.114_bib7","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1001\/jama.1982.03320390005003","article-title":"Calcium blockers for heart disease: two approved, more to come","volume":"247","author":"Kangilaski","year":"1917","journal-title":"JAMA"},{"key":"10.1016\/j.bbrc.2023.04.114_bib8","first-page":"309","article-title":"Clinical use of azelnidipine in the treatment of hypertension in Chinese patients","volume":"11","author":"Chen","year":"2015","journal-title":"Therapeut. Clin. Risk Manag."},{"key":"10.1016\/j.bbrc.2023.04.114_bib9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0014-2999(88)90640-1","article-title":"Effects of dihydropyridine calcium antagonists on rabbit renal Na,K-ATPase activity in\u00a0vitro","volume":"147","author":"Kloke","year":"1988","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2023.04.114_bib10","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/0006-2952(84)90463-5","article-title":"Stimulation of Na+,K+-ATPase of isolated smooth muscle membranes by the Ca2+ channel inhibitors, nimodipine and nitrendipine","volume":"33","author":"Pan","year":"1984","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbrc.2023.04.114_bib11","doi-asserted-by":"crossref","first-page":"9093","DOI":"10.1021\/acs.jmedchem.0c00796","article-title":"The optimization of a novel, weak bromo and extra terminal domain (BET) bromodomain fragment ligand to a potent and selective second bromodomain (BD2) inhibitor","volume":"63","author":"Seal","year":"2020","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.bbrc.2023.04.114_bib12","doi-asserted-by":"crossref","first-page":"10416","DOI":"10.1073\/pnas.1402695111","article-title":"SERS and MD simulation studies of a kinase inhibitor demonstrate the emergence of a potential drug discovery tool","volume":"111","author":"Karthigeyan","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2023.04.114_bib13","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/1892412","article-title":"1,4-Dihydropyridine derivatives: dihydronicotinamide analogues-model compounds targeting oxidative stress","author":"Velena","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.bbrc.2023.04.114_bib14","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2249.2009.03911.x","article-title":"Combination use of immune complexes and a Ca2(+) channel blocker azelnidipine enhances interleukin-12 p40 secretion without T helper type 17 cytokine secretion in human monocyte-derived dendritic cells","volume":"156","author":"Abe","year":"2009","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.bbrc.2023.04.114_bib15","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s00204-020-02944-7","article-title":"Synthetic cannabinoid CP-55,940 induces apoptosis in a human skeletal muscle model via regulation of CB1 receptors and L-type Ca(2+) channels","volume":"95","author":"Tomiyama","year":"2021","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.bbrc.2023.04.114_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2019.111800","article-title":"Felodipine blocks osteoclast differentiation and ameliorates estrogen-dependent bone loss in mice by modulating p38 signaling pathway","volume":"387","author":"Zhang","year":"2020","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bbrc.2023.04.114_bib17","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.chembiol.2019.06.006","article-title":"Engineering forward genetics into cultured cancer cells for chemical target identification","volume":"26","author":"Povedano","year":"2019","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.bbrc.2023.04.114_bib18","doi-asserted-by":"crossref","first-page":"6383","DOI":"10.1073\/pnas.1403608111","article-title":"PDGFRbeta reverses EphB4 signaling in alveolar rhabdomyosarcoma","volume":"111","author":"Aslam","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2023.04.114_bib19","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1158\/2159-8290.CD-13-0639","article-title":"Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors","volume":"4","author":"Shern","year":"2014","journal-title":"Cancer Discov."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X2300551X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X2300551X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T14:46:36Z","timestamp":1762094796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X2300551X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":21,"alternative-id":["S0006291X2300551X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2023.04.114","relation":{},"ISSN":["0006-291X"],"issn-type":[{"type":"print","value":"0006-291X"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure-activity relationship of dihydropyridines for rhabdomyosarcoma","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2023.04.114","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}